CRVO logo

CervoMed (CRVO) Selling, General & Administrative Expenses

Annual SGA

$6.52 M
+$4.38 M+204.77%

December 31, 2023

Summary

Performance

1-Year Change

+204.77%

3-Year Change

+1.17%

5-Year Change

+5.71%

15-Year Change

+5.29%

CRVO SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

12.72%
CRVO annual SGA is higher than 12.72% of companies in Healthcare sector

High & Low

All-time High

$11.09 M
CRVO annual SGA is currently -41.24% below its historical high of $11.09 million

3-Year Low

$2.14 M
CRVO annual SGA is currently +204.77% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
CRVO previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Apr 1, 2025
CRVO next annual earnings announcement is scheduled for Apr 1, 2025

OtherCRVOexpensesmetrics:

Annual Total Expenses

$7.81 M
CRVO annual total expenses is $7.81 million

Annual Operating Expenses

$7.81 M
CRVO annual total operating expenses is $7.81 million

Annual Cost Of Goods Sold

-
CRVO annual cost of goods sold value is unknown

Annual Interest Expense

$0.00
CRVO annual interest expense is $0.00

Quarterly SGA

$2.21 M
-$300.80 K-11.98%

September 30, 2024

Summary

Performance

3-Month Change

-11.98%

1-Year Change

+3.9%

3-Year Change

+3.9%

5-Year Change

+3.9%

CRVO Quarterly SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

19.47%
CRVO quarterly SGA is higher than 19.47% of companies in Healthcare sector

High & Low

All-time High

$4.73 M
CRVO quarterly SGA is currently -53.30% below its historical high of $4.73 million

3-Year Low

$558.10 K
CRVO quarterly SGA is currently +296.15% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
CRVO previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Apr 1, 2025
CRVO next earnings announcement is scheduled for Apr 1, 2025

OtherCRVOexpensesmetrics:

Quarterly Total Expenses

$5.40 M
CRVO quarterly total expenses is $5.40 million

Quarterly Operating Expenses

$5.40 M
CRVO quarterly total operating expenses is $5.40 million

Quarterly Cost Of Goods Sold

-
CRVO quarterly cost of goods sold value is unknown

Quarterly Interest Expense

-
CRVO quarterly interest expense value is unknown

TTM SGA

-$234.69 M
-$11.95 M-5.36%

September 30, 2024

Summary

Performance

3-Month Change

-2660.65%

1-Year Change

-3169.37%

3-Year Change

-3169.37%

5-Year Change

-3169.37%

CRVO TTM SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

74.98%
CRVO TTM SGA is higher than 74.98% of companies in Healthcare sector

High & Low

All-time High

-$12.74 M

3-Year Low

-$544.78 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
CRVO previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Apr 1, 2025
CRVO next earnings announcement is scheduled for Apr 1, 2025

OtherCRVOexpensesmetrics:

Annual Total Expenses

$7.81 M
CRVO annual total expenses is $7.81 million

Annual Operating Expenses

$7.81 M
CRVO annual total operating expenses is $7.81 million

TTM Cost Of Goods Sold

-
CRVO TTM cost of goods sold value is unknown

TTM Interest Expense

-
CRVO TTM interest expense value is unknown

Selling, General & Administrative Expenses Formula

SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development

Annual SGA

$6.52 M
CRVO annual SGA is $6.52 million

Annual Operating Expenses

$7.81 M
CRVO annual total operating expenses is $7.81 million

Annual Cost Of Goods Sold

-
CRVO annual cost of goods sold value is unknown

CRVO Selling, General & Administrative Expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+204.8%+3.9%-3169.4%
3 y3 years+1.2%+3.9%-3169.4%
5 y5 years+5.7%+3.9%-3169.4%

CRVO Selling, General & Administrative Expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-12.4%+204.8%-12.0%+296.1%-5.4%+56.9%
5 y5-year-12.4%+204.8%-12.0%+296.1%-5.4%+56.9%
alltimeall time-41.2%>+9999.0%-53.3%+284.2%-1741.9%+56.9%

CervoMed Selling, General & Administrative Expenses History

DateAnnualQuarterlyTTM
Sep 2024
-
$2.21 M(-12.0%)
$8.97 M(-2.2%)
Jun 2024
-
$2.51 M(+18.0%)
$9.17 M(+19.9%)
Mar 2024
-
$2.13 M(+0.6%)
$7.65 M(+17.3%)
Dec 2023
$6.52 M(+204.8%)
$2.12 M(-12.2%)
$6.52 M(+31.4%)
Sep 2023
-
$2.41 M(+142.8%)
$4.96 M(+58.8%)
Jun 2023
-
$992.60 K(-0.8%)
$3.13 M(-26.8%)
Mar 2023
-
$1.00 M(+79.3%)
$4.27 M(-20.9%)
Dec 2022
$2.14 M(-71.3%)
-
-
Dec 2022
-
$558.10 K(-2.7%)
$5.40 M(-20.3%)
Sep 2022
-
$573.50 K(-73.2%)
$6.77 M(-16.7%)
Jun 2022
-
$2.14 M(+0.4%)
$8.13 M(+3.8%)
Mar 2022
-
$2.13 M(+10.0%)
$7.83 M(+5.2%)
Dec 2021
$7.45 M(+15.5%)
$1.93 M(+0.2%)
$7.45 M(+6.5%)
Sep 2021
-
$1.93 M(+5.1%)
$6.99 M(-2.5%)
Jun 2021
-
$1.84 M(+5.4%)
$7.17 M(+5.6%)
Mar 2021
-
$1.74 M(+17.8%)
$6.79 M(+5.4%)
Dec 2020
$6.44 M(+33.3%)
$1.48 M(-30.0%)
$6.44 M(+3.3%)
Sep 2020
-
$2.11 M(+44.9%)
$6.24 M(+15.2%)
Jun 2020
-
$1.46 M(+4.6%)
$5.42 M(+7.8%)
Mar 2020
-
$1.39 M(+9.3%)
$5.03 M(+4.0%)
Dec 2019
$4.83 M(-21.6%)
$1.27 M(-1.2%)
$4.83 M(-2.9%)
Sep 2019
-
$1.29 M(+20.8%)
$4.98 M(-5.7%)
Jun 2019
-
$1.07 M(-11.0%)
$5.28 M(-10.1%)
Mar 2019
-
$1.20 M(-15.4%)
$5.87 M(-4.8%)
Dec 2018
$6.17 M(-0.4%)
$1.42 M(-10.7%)
$6.17 M(+2.2%)
Sep 2018
-
$1.59 M(-4.3%)
$6.03 M(+0.5%)
Jun 2018
-
$1.66 M(+10.9%)
$6.00 M(-2.2%)
Mar 2018
-
$1.50 M(+16.7%)
$6.14 M(-0.9%)
Dec 2017
$6.19 M(-44.2%)
$1.28 M(-17.7%)
$6.19 M(+4.4%)
Sep 2017
-
$1.56 M(-13.2%)
$5.93 M(-27.9%)
Jun 2017
-
$1.80 M(+15.6%)
$8.22 M(-6.3%)
Mar 2017
-
$1.55 M(+51.8%)
$8.78 M(-20.8%)
Dec 2016
$11.09 M(+339.8%)
$1.02 M(-73.4%)
$11.09 M(-2.4%)
Sep 2016
-
$3.85 M(+64.0%)
$11.36 M(+43.3%)
Jun 2016
-
$2.35 M(-39.2%)
$7.93 M(+33.8%)
Mar 2016
-
$3.86 M(+198.4%)
$5.93 M(+134.9%)
Dec 2015
$2.52 M(-47.0%)
$1.29 M(+206.8%)
$2.52 M(+33.0%)
Sep 2015
-
$422.00 K(+21.6%)
$1.90 M(-43.3%)
Jun 2015
-
$347.10 K(-24.3%)
$3.34 M(-20.5%)
Mar 2015
-
$458.80 K(-31.4%)
$4.21 M(-11.6%)
Dec 2014
$4.76 M
$668.60 K(-64.2%)
$4.76 M(-46.1%)
Sep 2014
-
$1.87 M(+54.4%)
$8.83 M(+10.6%)
Jun 2014
-
$1.21 M(+19.8%)
$7.98 M(+5.4%)
DateAnnualQuarterlyTTM
Mar 2014
-
$1.01 M(-78.6%)
$7.57 M(+3.3%)
Dec 2013
$7.33 M(+9.4%)
$4.73 M(+361.8%)
$7.33 M(+111.0%)
Sep 2013
-
$1.03 M(+27.4%)
$3.48 M(-11.7%)
Jun 2013
-
$804.60 K(+4.8%)
$3.93 M(-27.6%)
Mar 2013
-
$767.80 K(-12.5%)
$5.43 M(-18.9%)
Dec 2012
$6.70 M(-33.0%)
$877.60 K(-40.9%)
$6.70 M(-16.3%)
Sep 2012
-
$1.48 M(-35.6%)
$8.01 M(-24.7%)
Jun 2012
-
$2.30 M(+13.3%)
$10.64 M(+2.5%)
Mar 2012
-
$2.03 M(-7.0%)
$10.38 M(+9.2%)
Dec 2011
$10.01 M(+47.8%)
$2.19 M(-46.9%)
$9.50 M(+0.4%)
Sep 2011
-
$4.11 M(+101.4%)
$9.46 M(+35.6%)
Jun 2011
-
$2.04 M(+76.2%)
$6.98 M(+3.5%)
Mar 2011
-
$1.16 M(-45.9%)
$6.74 M(-0.4%)
Dec 2010
$6.77 M(+133.2%)
$2.14 M(+31.5%)
$6.77 M(+15.1%)
Sep 2010
-
$1.63 M(-9.8%)
$5.88 M(+22.4%)
Jun 2010
-
$1.81 M(+52.7%)
$4.81 M(+40.9%)
Mar 2010
-
$1.18 M(-5.8%)
$3.41 M(+37.3%)
Dec 2009
$2.90 M(+205.1%)
$1.26 M(+126.1%)
$2.48 M(+74.6%)
Sep 2009
-
$556.00 K(+34.3%)
$1.42 M(+24.6%)
Jun 2009
-
$414.00 K(+60.6%)
$1.14 M(+20.5%)
Mar 2009
-
$257.80 K(+31.7%)
$947.90 K(-0.3%)
Dec 2008
$950.80 K(+1603.9%)
$195.70 K(-28.7%)
$950.80 K(-486.7%)
Sep 2008
-
$274.50 K(+24.8%)
-$245.90 K(-7.4%)
Jun 2008
-
$219.90 K(-15.7%)
-$265.60 K(+138.6%)
Mar 2008
-
$260.70 K(-126.0%)
-$111.30 K(-299.5%)
Dec 2007
$55.80 K(+33.2%)
-$1.00 M(-492.9%)
$55.80 K(-94.9%)
Sep 2007
-
$254.80 K(-31.9%)
$1.09 M(+30.0%)
Jun 2007
-
$374.20 K(-12.5%)
$836.70 K(+65.0%)
Mar 2007
-
$427.80 K(+1275.6%)
$507.20 K(+511.1%)
Dec 2006
$41.90 K(-54.6%)
$31.10 K(+763.9%)
$83.00 K(+59.9%)
Sep 2006
-
$3600.00(-91.9%)
$51.90 K(+7.5%)
Jun 2006
-
$44.70 K(+1141.7%)
$48.30 K(+1241.7%)
Mar 2006
-
$3600.00(-99.8%)
$3600.00(-100.0%)
Dec 2005
$92.20 K(-98.6%)
-
-
Sep 2000
-
$2.10 M(+7.2%)
$8.18 M(+7.9%)
Jun 2000
-
$1.96 M(+15.2%)
$7.58 M(+8.0%)
Mar 2000
-
$1.70 M(-29.6%)
$7.02 M(+11.1%)
Dec 1999
$6.42 M(+100.6%)
$2.42 M(+61.3%)
$6.32 M(+134.0%)
Sep 1999
-
$1.50 M(+7.1%)
$2.70 M(-3.6%)
Jun 1999
-
$1.40 M(+40.0%)
$2.80 M(+100.0%)
Mar 1999
-
$1.00 M(-183.3%)
$1.40 M(+250.0%)
Dec 1998
$3.20 M
-$1.20 M(-175.0%)
$400.00 K(-75.0%)
Sep 1998
-
$1.60 M
$1.60 M

FAQ

  • What is CervoMed annual SGA?
  • What is the all time high annual SGA for CervoMed?
  • What is CervoMed annual SGA year-on-year change?
  • What is CervoMed quarterly SGA?
  • What is the all time high quarterly SGA for CervoMed?
  • What is CervoMed quarterly SGA year-on-year change?
  • What is CervoMed TTM SGA?
  • What is the all time high TTM SGA for CervoMed?
  • What is CervoMed TTM SGA year-on-year change?

What is CervoMed annual SGA?

The current annual SGA of CRVO is $6.52 M

What is the all time high annual SGA for CervoMed?

CervoMed all-time high annual SGA is $11.09 M

What is CervoMed annual SGA year-on-year change?

Over the past year, CRVO annual SGA has changed by +$4.38 M (+204.77%)

What is CervoMed quarterly SGA?

The current quarterly SGA of CRVO is $2.21 M

What is the all time high quarterly SGA for CervoMed?

CervoMed all-time high quarterly SGA is $4.73 M

What is CervoMed quarterly SGA year-on-year change?

Over the past year, CRVO quarterly SGA has changed by +$83.00 K (+3.90%)

What is CervoMed TTM SGA?

The current TTM SGA of CRVO is -$234.69 M

What is the all time high TTM SGA for CervoMed?

CervoMed all-time high TTM SGA is -$12.74 M

What is CervoMed TTM SGA year-on-year change?

Over the past year, CRVO TTM SGA has changed by -$242.34 M (-3169.37%)